TABLE 2.
Sample characterization (by Architect assay, WB, and HIV RNA detection)a | Total no. tested | No. negb | No. positive with BioPlex 2200 HIV Ag-Ab |
Total no. | Sensitivity (%) | Specificity (%) | Diffd capability (%) | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Ag p24 | Ab HIV-1 | Ag + Ab | Ab HIV-2 | Undiffc | |||||||
Negative | 1,470 | 1,462 | 1 | 7 | 0 | 0 | 0 | 8 | 99.5 | ||
HIV-1 (no AHI) | 420 | 0 | 0 | 420 | 0 | 0 | 420 | 100 | 100 | ||
HIV-1 (AHI) | 11 | 0 | 2 | 3 | 5 | 0 | 1 | 11 | 100 | 90.9 | |
HIV-2 | 86 | 0 | 0 | 0 | 0 | 78 | 8 | 86 | 100 | 90.7 | |
HIV-1 and HIV-2 | 7 | 0 | 0 | 0 | 0 | 0 | 7 | 7 | 100 | 100 |
WB, Western blot.
neg, negative.
Undiff, undifferentiating.
Diff, differentiation.